Literature DB >> 15249162

Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices.

David A S Parker1, Jennifer Ong, Victor Marino, David I B Kerr.   

Abstract

In electrically stimulated rat neocortical brain slices preloaded with [3H]gamma-aminobutyric acid (GABA) or [3H]glutamic acid, the pharmacological actions of 1-(aminomethyl)-cyclohexaneacetic acid (gabapentin, Gp) were compared with the GABAB receptor agonists baclofen (Bac) and (3-amino-2-(S)-hydroxypropyl)-methylphosphinic acid (CGP 44532). Gabapentin, baclofen and CGP 44532 all reduced the electrically stimulated release of [3H]glutamic acid (IC50=20 microM, 0.8 microM and 2 microM, respectively). These effects were sensitive to the GABAB receptor antagonists (+)-(S)-5,5 dimethylmorpholinyl-2-acetic acid (Sch 50911) or N-3-[[1-(S)-(3,4-dichlorophenyl)ethyl]amino]-2-(S)-hydroxypropyl-P-(cyclo-hexylmethyl)-phosphinic acid (CGP 54626). By contrast, gabapentin was without effect on the release of [3H]GABA, whilst baclofen (IC50=8 microM) and CGP 44532 (IC50=1 microM) inhibited [3H]GABA release. It is concluded that gabapentin selectively activates presynaptic GABAB heteroreceptors, but not GABAB autoreceptors, and may be a useful ligand to discriminate between presynaptic GABAB receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249162     DOI: 10.1016/j.ejphar.2004.05.029

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Not another gabapentin mechanism!

Authors:  Graeme J Sills
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

Review 2.  Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Andrea Diana; Rita Pillai; Paolo Bongioanni; Aidan G O'Keeffe; Robert G Miller; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-09

Review 3.  Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Authors:  Cory Toth
Journal:  Ther Adv Drug Saf       Date:  2014-02

4.  Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-23       Impact factor: 3.000

5.  Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  Mol Pharmacol       Date:  2018-07-18       Impact factor: 4.436

6.  Gabapentin for smoking cessation.

Authors:  Amit Sood; Jon O Ebbert; Kirk D Wyatt; Ivana T Croghan; Darrell R Schroeder; Richa Sood; J Taylor Hays
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

7.  Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro.

Authors:  S D Greenhill; R S G Jones
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

8.  Cellular and behavioral interactions of gabapentin with alcohol dependence.

Authors:  Marisa Roberto; Nicholas W Gilpin; Laura E O'Dell; Maureen T Cruz; Andrew C Morse; George R Siggins; George F Koob
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

9.  Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study.

Authors:  R J M Governo; P G Morris; C A Marsden; V Chapman
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 10.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.